Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
Check against the official notice below — it lists the full affected range.
King Legacy, a subsidiary of Pfizer, is recalling Levoxyl (levothyroxine sodium) tablets, 50 mcg, distributed nationwide and in Puerto Rico. The recall affects approximately 195,699 bottles in two package sizes: 100-count bottles and 1000-count bottles. The products were found to be subpotent, meaning they contained less active ingredient than specified at their expiration dates. Specific lot numbers and expiration dates ranging from April 2013 through November 2013 are affected.
The recall involves thirteen specific lots across both bottle sizes. Consumers affected by this recall should contact the source for information on how to proceed, as the recall record does not specify a remedy or next steps for affected consumers.
Written by software from the official notice below. Not reviewed by a lawyer.
Subpotent Drug: The products were below specification for potency at the expiry stability point.
Reason for recall: Subpotent Drug: The products were below specification for potency at the expiry stability point. Distribution: Nationwide and Puerto Rico Quantity: 195,699 bottles Lot/code info: Lot # a) 64934, Exp. 4/13; 65059, Exp. 5/13; 65179, Exp. 4/13; 65630, Exp. 7/13; 65916, Exp. 8/13; 66367, Exp. 10/13; and 66718, Exp. 11/13; b) 64338, Exp. 4/13; 64932, Exp. 4/13; 65060, Exp. 5/13; 65235, Exp. 6/13; 65853, Exp. 6/13; and 65962, Exp. 7/13
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.